Table 2.
Total | Acyl Chain | Glycerol | PC Head Group | |||||
---|---|---|---|---|---|---|---|---|
Residue | Number | Contacts | Number | Contacts | Number | Contacts | Number | Contacts |
ALA | 4 (6.6%) | 56 (4.5%) | 3 (5.8%) | 46 (4.7%) | 0 (0.0%) | 0 (0.0%) | 1 (4.0%) | 10 (4.5%) |
ARG | 4 (6.6%) | 112 (9.0%) | 1 (1.9%) | 36 (3.6%) | 2 (14.3%) | 18 (27.7%) | 4 (16.0%) | 66 (29.7%) |
ASN | 1 (1.6%) | 7 (0.6%) | 1 (1.9%) | 4 (0.4%) | 0 (0.0%) | 0 (0.0%) | 1 (4.0%) | 3 (1.4%) |
CYS | 1 (1.6%) | 10 (0.8%) | 1 (1.9%) | 10 (1.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
GLN | 1 (1.6%) | 34 (2.7%) | 1 (1.9%) | 17 (1.7%) | 0 (0.0%) | 0 (0.0%) | 1 (4.0%) | 17 (7.7%) |
GLY | 2 (3.3%) | 25 (2.0%) | 1 (1.9%) | 22 (2.2%) | 0 (0.0%) | 0 (0.0%) | 1 (4.0%) | 3 (1.4%) |
HIS | 1 (1.6%) | 22 (1.8%) | 1 (1.9%) | 22 (2.2%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
ILE | 5 (8.2%) | 106 (8.5%) | 5 (8.9%) | 106 (10.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
LEU | 11 (18.0%) | 216 (17.4%) | 10 (49.2%) | 172 (17.4%) | 4 (28.6%) | 12 (18.5%) | 5 (20.0%) | 36 (16.2%) |
PHE | 9 (14.8%) | 185 (14.9%) | 9 (17.3%) | 155 (15.7%) | 3 (21.4%) | 16 (24.6%) | 2 (8.0%) | 23 (10.4%) |
PRO | 2 (3.3%) | 9 (0.7%) | 1 (1.9%) | 1 (0.1%) | 0 (0.0%) | 0 (0.0%) | 2 (8.0%) | 8 (3.6%) |
SER | 3 (4.9%) | 90 (7.3%) | 2 (3.6%) | 60 (6.1%) | 1 (7.1%) | 6 (9.2%) | 3 (12.0%) | 28 (12.6%) |
THR | 4 (6.6%) | 24 (1.9%) | 3 (5.8%) | 12 (1.2%) | 0 (0.0%) | 0 (0.0%) | 3 (12.0%) | 12 (5.4%) |
TRP | 3 (4.9%) | 176 (14.2%) | 3 (5.8%) | 160 (16.2%) | 2 (14.3%) | 6 (9.2%) | 0 (0.0%) | 0 (0.0%) |
TYR | 1 (1.6%) | 59 (4.8%) | 1 (1.9%) | 57 (5.8%) | 1 (7.1%) | 5 (7.7%) | 1 (4.0%) | 15 (6.8%) |
VAL | 9 (14.8%) | 109 (8.8%) | 9 (17.3%) | 107 (10.8%) | 1 (7.1%) | 2 (3.1%) | 1 (4.0%) | 1 (0.5%) |
TOTAL | 61 | 1240 | 52 | 987 | 14 | 65 | 25 | 222 |